Net Cash Provided by (Used in) Operating Activities of Perspective Therapeutics, Inc. from 30 Sep 2010 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary: Perspective Therapeutics, Inc. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 30 Sep 2010 to 31 Mar 2025.
Perspective Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $21,582,000, a 256% decline year-over-year.
Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $18,294,000, a 50% increase from 2023.
Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $36,913,000, a 255% decline from 2022.
Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $10,401,000, a 267% decline from 2021.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Operating Activities, Annual (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

Perspective Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$21,582,000	-$35,430,000	-256%	01 Jan 2025	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q1 2024	$13,848,000	+$23,571,000		01 Jan 2024	31 Mar 2024	10-Q	12 May 2025	2025	Q1
Q1 2023	$9,723,000	-$8,299,000	-583%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2024	2024	Q1
Q3 2022	$1,763,000	+$321,000	+15%	01 Jul 2022	30 Sep 2022	10-Q	14 Nov 2022	2023	Q1
Q1 2022	$1,424,000			01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q3 2021	$2,084,000	-$1,746,000	-517%	01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2023	Q1
Q3 2020	$338,000	+$315,000	+48%	01 Jul 2020	30 Sep 2020	10-Q	10 Nov 2021	2022	Q1
Q3 2019	$653,000	+$959,000	+59%	01 Jul 2019	30 Sep 2019	10-Q	13 Nov 2020	2021	Q1
Q3 2018	$1,612,000	+$49,000	+3%	01 Jul 2018	30 Sep 2018	10-Q	13 Nov 2019	2020	Q1
Q3 2017	$1,661,000	-$308,000	-23%	01 Jul 2017	30 Sep 2017	10-Q	09 Nov 2018	2019	Q1
Q3 2016	$1,353,000			01 Jul 2016	30 Sep 2016	10-Q	14 Nov 2017	2018	Q1
Q3 2013	$892,021	+$46,608	+5%	01 Jul 2013	30 Sep 2013	10-Q	14 Nov 2013	2014	Q1
Q3 2012	$938,629	-$396,543	-73%	01 Jul 2012	30 Sep 2012	10-Q	14 Nov 2013	2014	Q1
Q3 2011	$542,086	+$98,189	+15%	01 Jul 2011	30 Sep 2011	10-Q	14 Nov 2012	2013	Q1
Q3 2010	$640,275			01 Jul 2010	30 Sep 2010	10-Q/A	13 Dec 2011	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$18,294,000	+$18,619,000	+50%	01 Jan 2024	31 Dec 2024	10-K/A	28 Mar 2025	2024	FY
2023	$36,913,000	-$26,512,000	-255%	01 Jan 2023	31 Dec 2023	10-K/A	28 Mar 2025	2024	FY
2022	$10,401,000	-$7,564,000	-267%	01 Jan 2022	31 Dec 2022	10-K	28 Mar 2024	2023	FY
2021	$2,837,000	+$804,000	+22%	01 Jul 2020	30 Jun 2021	10-KT	01 May 2023	2023	Q1
2020	$3,641,000	+$1,408,000	+28%	01 Jul 2019	30 Jun 2020	10-KT	01 May 2023	2023	Q1
2019	$5,049,000	+$663,000	+12%	01 Jul 2018	30 Jun 2019	10-K	27 Sep 2021	2021	FY
2018	$5,712,000	$0	0%	01 Jul 2017	30 Jun 2018	10-K	25 Sep 2020	2020	FY
2017	$5,712,000	-$1,828,000	-47%	01 Jul 2016	30 Jun 2017	10-K	27 Sep 2019	2019	FY
2016	$3,884,000			01 Jul 2015	30 Jun 2016	10-K	26 Sep 2018	2018	FY
2013	$3,056,267	-$608,492	-25%	01 Jul 2012	30 Jun 2013	10-K	30 Sep 2013	2013	FY
2012	$2,447,775	-$28,865	-1.2%	01 Jul 2011	30 Jun 2012	10-K	30 Sep 2013	2013	FY
2011	$2,418,910			01 Jul 2010	30 Jun 2011	10-K/A	26 Oct 2012	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.